Parkside Financial Bank & Trust’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.7K | Buy |
180
+168
| +1,400% | +$1.84K | ﹤0.01% | 2176 |
|
|
2025
Q4 | $150 | Sell |
12
-73
| -86% | -$971 | ﹤0.01% | 2648 |
|
|
2025
Q3 | $1.22K | Sell |
85
-143
| -63% | -$1.96K | ﹤0.01% | 2205 |
|
|
2025
Q2 | $2.8K | Buy |
228
+167
| +274% | +$2.42K | ﹤0.01% | 1887 |
|
|
2025
Q1 | $1.34K | Buy |
61
+25
| +69% | +$588 | ﹤0.01% | 2007 |
|
|
2024
Q4 | $817 | Buy |
+36
| New | +$786 | ﹤0.01% | 1778 |
|
|
2024
Q3 | – | Sell |
-77
| Closed | -$2.25K | – | 2114 |
|
|
2024
Q2 | $2.25K | Sell |
77
-921
| -92% | -$27.3K | ﹤0.01% | 1538 |
|
|
2024
Q1 | $35.4K | Buy |
998
+859
| +618% | +$34.4K | 0.01% | 865 |
|
|
2023
Q4 | $6.05K | Buy |
139
+48
| +53% | +$1.89K | ﹤0.01% | 1260 |
|
|
2023
Q3 | $3.48K | Sell |
91
-13
| -13% | -$547 | ﹤0.01% | 1495 |
|
|
2023
Q2 | $4.28K | Sell |
104
-96
| -48% | -$4.62K | ﹤0.01% | 1426 |
|
|
2023
Q1 | $11.5K | Sell |
200
-11
| -5% | -$620 | ﹤0.01% | 1059 |
|
|
2022
Q4 | $11.8K | Buy |
+211
| New | +$10.7K | ﹤0.01% | 1006 |
|
|
2022
Q3 | – | Sell |
-21
| Closed | -$1K | – | 1858 |
|
|
2022
Q2 | $1K | Sell |
21
-20
| -49% | -$1.2K | ﹤0.01% | 1720 |
|
|
2022
Q1 | $3K | Buy |
41
+8
| +24% | +$527 | ﹤0.01% | 1488 |
|
|
2021
Q4 | $2K | Buy |
33
+7
| +27% | +$474 | ﹤0.01% | 1608 |
|
|
2021
Q3 | $2K | Hold |
26
| – | – | ﹤0.01% | 1554 |
|
|
2021
Q2 | $2K | Hold |
26
| – | – | ﹤0.01% | 1539 |
|
|
2021
Q1 | $2K | Buy |
26
+17
| +189% | +$1.15K | ﹤0.01% | 1494 |
|
|
2020
Q4 | $1K | Buy |
9
+5
| +125% | +$269 | ﹤0.01% | 1526 |
|
|
2020
Q3 | $0 | Buy |
+4
| New | +$190 | ﹤0.01% | 1577 |
|
|
2018
Q4 | – | Sell |
-194
| Closed | -$12K | – | 1502 |
|
|
2018
Q3 | $12K | Hold |
194
| – | – | ﹤0.01% | 730 |
|
|
2018
Q2 | $12K | Sell |
194
-48
| -20% | -$2.97K | ﹤0.01% | 716 |
|
|
2018
Q1 | $13K | Sell |
242
-107
| -31% | -$5.61K | ﹤0.01% | 668 |
|
|
2017
Q4 | $16K | Sell |
349
-4
| -1% | -$196 | 0.01% | 625 |
|
|
2017
Q3 | $18K | Sell |
353
-398
| -53% | -$20.4K | 0.01% | 586 |
|
|
2017
Q2 | $41K | Sell |
751
-234
| -24% | -$11.2K | 0.02% | 373 |
|
|
2017
Q1 | $41K | Buy |
985
+55
| +6% | +$2.35K | 0.02% | 361 |
|
|
2016
Q4 | $40K | Sell |
930
-128
| -12% | -$5.2K | 0.02% | 377 |
|
|
2016
Q3 | $44K | Sell |
1,058
-8
| -0.8% | -$335 | 0.02% | 392 |
|
|
2016
Q2 | $43K | Hold |
1,066
| – | – | 0.02% | 372 |
|
|
2016
Q1 | $36K | Buy |
1,066
+54
| +5% | +$1.68K | 0.02% | 397 |
|
|
2015
Q4 | $35K | Buy |
1,012
+26
| +3% | +$813 | 0.02% | 398 |
|
|
2015
Q3 | $29K | Buy |
+986
| New | +$30.8K | 0.02% | 403 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
Parkside Financial Bank & Trust's IART Position: Q1 2026 in Review
Parkside Financial Bank & Trust increased its Integra LifeSciences (IART) stake by 1,400% in Q1 2026, buying an estimated $1.84K and bringing the position to 180 shares worth $1.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2176.
Parkside Financial Bank & Trust first reported a position in IART in Q3 2015 and has held it in 34 quarters since. The position peaked at $44K in Q3 2016. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Parkside Financial Bank & Trust held 180 shares of Integra LifeSciences worth $1.7K as of Q1 2026.
- Parkside Financial Bank & Trust bought 168 Integra LifeSciences shares in Q1 2026, an estimated $1.84K.
- Integra LifeSciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2176 holding.
- Parkside Financial Bank & Trust first reported a position in Integra LifeSciences in Q3 2015 and has held it in 34 quarters since.
- Parkside Financial Bank & Trust's Integra LifeSciences position peaked at $44K in Q3 2016.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.